Pancreatic Neoplasms: all 3,310 studies
Page 9 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy ResponseRecruitingNCT04588025Not applicable
- Para-aortic Lymphnodes Removal During Upfront PancreaticoduodenectomyRecruitingNCT04571294Not applicable
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAvailableNCT04566393
- Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic CancerRecruitingNCT04536220
- Pancreatic Radiofrequency Under High Echo-endoscopy in the Management of Pancreatic Neuroendocrine TumorsRecruitingNCT04520932Not applicable
- Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During RadiotherapyRecruitingNCT04517019Not applicable
- OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.RecruitingNCT04493632
- Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue InjuryRecruitingNCT04485286Phase 2
- Diagnostic Strategies, Risk Assessment and Progression of Pancreatic CystsRecruitingNCT04473794
- Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam TherapyEnrolling by invitationNCT04466189
- Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsRecruitingNCT04429542Phase 1
- BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid TumoursRecruitingNCT04421820Phase 1/2
- The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic CancerRecruitingNCT04406831
- A Phase I/IIa Study of EF-009 in Patients With Pancreatic CancerNot yet recruitingNCT04381130Phase 1/2
- SERum-bank for PANcreatic CancerRecruitingNCT04374175
- NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic CancerRecruitingNCT04371224Phase 2
- Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive MethodologyRecruitingNCT04370574
- RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic CancerRecruitingNCT04338763Phase 1
- Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic CancerRecruitingNCT04324307Phase 1/2
- Contrast Enhanced Endoscopic Ultrasound in Pancreas LesionsRecruitingNCT04324294Phase 1
- UCSF PANC Cyst RegistryRecruitingNCT04291651
- Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic CancerRecruitingNCT04289792Phase 2
- Systemic Therapy With a Loco-regional Treatment in Patients With Locally Advanced Pancreatic CancerRecruitingNCT04276857Not applicable
- Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated BiomarkersRecruitingNCT04239573
- Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsRecruitingNCT04222413Phase 1
- The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the ElderlyRecruitingNCT04164602
- Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic AdenocarcinomaRecruitingNCT04157127Phase 1
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsRecruitingNCT04150042Phase 1
- Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic CancerRecruitingNCT04146298Phase 1/2
- Prospective Monocentric Clinical-biological DatabaseRecruitingNCT04136132Not applicable
- Stereotactic Magnetic Resonance Guided Radiation TherapyRecruitingNCT04115254Not applicable
- Quebec Pancreas Cancer StudyRecruitingNCT04104230
- PACAREG: a Multicenter Registry Trial in Pancreatic Ductal AdencarcinomaRecruitingNCT04099134
- Registry of Subjects at Risk of Pancreatic CancerRecruitingNCT04095195
- BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAvailableNCT04091295
- mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer PatientsRecruitingNCT04084496Phase 2
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruitingNCT04075305
- Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine TumorsRecruitingNCT04074135Phase 2
- Heterotopic Ossification in Abdominal Incision and Pancreatic CancerNot yet recruitingNCT04049461
- Lidocaine Infusion in Pancreatic CancerRecruitingNCT04048278Early Phase 1
- PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic TumorsRecruitingNCT04011982
- Targeted Pathway Inhibition in Patients With Pancreatic CancerRecruitingNCT04005690Early Phase 1
- Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic CancerRecruitingNCT03977233Phase 2
- Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled TrialRecruitingNCT03957135Not applicable
- A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes MellitusRecruitingNCT03937453
- Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsRecruitingNCT03924466Phase 2
- Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative SurgeryRecruitingNCT03838029Phase 2
- Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
- Microbial Diversity of Pancreatic DiseasesRecruitingNCT03809247
- Registry of Pancreatic DiseaseRecruitingNCT03807687
- New Biomarkers in Pancreatic Cancer Using EXPEL ConceptRecruitingNCT03791073
- Comparing Laparoscopic and Open Surgery for Pancreatic CarcinomaRecruitingNCT03785743Not applicable
- Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1RecruitingNCT03777462Phase 2
- Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsRecruitingNCT03755739Phase 2/3
- The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic CancerRecruitingNCT03747588Not applicable
- A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic CancerRecruitingNCT03721744Phase 2/3
- Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic CancerRecruitingNCT03711890Not applicable
- The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder CancerRecruitingNCT03637569
- iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D MutationRecruitingNCT03608631Phase 1/2
- MR Guidance for Liver and PancreasRecruitingNCT03582189
- Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient with Pancreatic CancerRecruitingNCT03579836Phase 1/2
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/2
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowRecruitingNCT03551951
- Tumour Regulatory Molecules in Early Pancreatic Cancer DetectionRecruitingNCT03536793
- Gemcitabine and Celecoxib Combination Therapy in Treating Patients With R0 Resection Pancreatic CancerRecruitingNCT03498326Phase 2
- Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic CancerRecruitingNCT03492671Phase 2
- Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic LesionsRecruitingNCT03492151
- Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic AdenocarcinomaRecruitingNCT03484299Phase 1
- Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid TumorsRecruitingNCT03454035Phase 1
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction ChemotherapyRecruitingNCT03398291Phase 3
- A Study of Blood Based Biomarkers for Pancreas AdenocarcinomaRecruitingNCT03334708
- Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy TrialRecruitingNCT03322995Phase 2
- BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")RecruitingNCT03311776
- A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic CancerNot yet recruitingNCT03301805Phase 2
- Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas CancerRecruitingNCT03260842
- A Pancreatic Cancer Screening Study in Hereditary High Risk IndividualsRecruitingNCT03250078
- EUS-guided RFA for Pancreatic NeoplasmsRecruitingNCT03218345Not applicable
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 PatientsRecruitingNCT03190941Phase 1/2
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsRecruitingNCT03175224Phase 2
- Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid TumorRecruitingNCT03093688Phase 1/2
- Familial Investigations of Childhood Cancer PredispositionRecruitingNCT03050268
- Pancreatic Cancer Registry: For Any Person With a Personal or Family HistoryRecruitingNCT02886247
- Pancreatic Surgical DatabaseRecruitingNCT02871336
- Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic AnalysisRecruitingNCT02869802
- Institut Paoli-Calmettes Pancreatic Neoplasms DatabaseRecruitingNCT02869581
- Contrast EUS of the PancreasRecruitingNCT02863770Not applicable
- Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR SourceRecruitingNCT02843945Phase 1/2
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersRecruitingNCT02838836
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing CancersRecruitingNCT02830724Phase 1/2
- Pancreas Registry and High Risk RegistryRecruitingNCT02775461
- American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) RegistryRecruitingNCT02674100
- Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the PancreasRecruitingNCT02598349Phase 2
- Feasibility of the LUM Imaging System for Detection of Gastrointestinal CancersRecruitingNCT02584244Phase 1/2
- Preliminary Evaluation of Screening for Pancreatic Cancer in Patients With Inherited Genetic RiskRecruitingNCT02478892
- Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic CancerRecruitingNCT02393703
- Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary CancerRecruitingNCT02361320Not applicable
- Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver MetastasesRecruitingNCT02185443Phase 2
- Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.RecruitingNCT02078245
- Integrated Cancer Repository for Cancer ResearchRecruitingNCT02012699